Europe Osteoporosis Drugs Market Report 2016

November 2016 | 120 pages | ID: E1B0A7674A4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Osteoporosis Drugs

Revenue, means the sales value of Osteoporosis Drugs

This report studies sales (consumption) of Osteoporosis Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Novartis
• Merck & Co
• Eli Lilly
• Amgen
• Abiogen Pharma
• Deltanoid Pharmaceuticals
• F. Hoffmann La Roche
• GlaxoSmithKline
• IMMD
• Ligand Pharmaceuticals
• NPS Pharma
• Pantarhei Bioscience
• Pfizer
• PhytoHealth
• Radius Health
• Shenzhen Haiwang
• Kunming Baker Norton
• Chia Tai Tianqing

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Osteoporosis Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antiresorptive Medications
• Anabolic Medications
• Others

Split by application, this report focuses on sales, market share and growth rate of Osteoporosis Drugs in each application, can be divided into

• Hospital use
• Clinic use
• Others

Contents

Europe Osteoporosis Drugs Market Report 2016

1 OSTEOPOROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Osteoporosis Drugs
1.2 Classification of Osteoporosis Drugs
  1.2.1 Antiresorptive Medications
  1.2.2 Anabolic Medications
  1.2.3 Others
1.3 Application of Osteoporosis Drugs
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Others
1.4 Osteoporosis Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Osteoporosis Drugs (2011-2021)
  1.5.1 Europe Osteoporosis Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Osteoporosis Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE OSTEOPOROSIS DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Osteoporosis Drugs Market Competition by Manufacturers
  2.1.1 Europe Osteoporosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Osteoporosis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Osteoporosis Drugs (Volume and Value) by Type
  2.2.1 Europe Osteoporosis Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Osteoporosis Drugs (Volume and Value) by Countries
  2.3.1 Europe Osteoporosis Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Osteoporosis Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Osteoporosis Drugs (Volume) by Application

3 GERMANY OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Osteoporosis Drugs Sales and Value (2011-2016)
  3.1.1 Germany Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Osteoporosis Drugs Sales Price Trend (2011-2016)
3.2 Germany Osteoporosis Drugs Sales and Market Share by Manufacturers
3.3 Germany Osteoporosis Drugs Sales and Market Share by Type
3.4 Germany Osteoporosis Drugs Sales and Market Share by Application

4 FRANCE OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Osteoporosis Drugs Sales and Value (2011-2016)
  4.1.1 France Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Osteoporosis Drugs Sales Price Trend (2011-2016)
4.2 France Osteoporosis Drugs Sales and Market Share by Manufacturers
4.3 France Osteoporosis Drugs Sales and Market Share by Type
4.4 France Osteoporosis Drugs Sales and Market Share by Application

5 UK OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Osteoporosis Drugs Sales and Value (2011-2016)
  5.1.1 UK Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Osteoporosis Drugs Sales Price Trend (2011-2016)
5.2 UK Osteoporosis Drugs Sales and Market Share by Manufacturers
5.3 UK Osteoporosis Drugs Sales and Market Share by Type
5.4 UK Osteoporosis Drugs Sales and Market Share by Application

6 RUSSIA OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Osteoporosis Drugs Sales and Value (2011-2016)
  6.1.1 Russia Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Osteoporosis Drugs Sales Price Trend (2011-2016)
6.2 Russia Osteoporosis Drugs Sales and Market Share by Manufacturers
6.3 Russia Osteoporosis Drugs Sales and Market Share by Type
6.4 Russia Osteoporosis Drugs Sales and Market Share by Application

7 ITALY OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Osteoporosis Drugs Sales and Value (2011-2016)
  7.1.1 Italy Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Osteoporosis Drugs Sales Price Trend (2011-2016)
7.2 Italy Osteoporosis Drugs Sales and Market Share by Manufacturers
7.3 Italy Osteoporosis Drugs Sales and Market Share by Type
7.4 Italy Osteoporosis Drugs Sales and Market Share by Application

8 SPAIN OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Osteoporosis Drugs Sales and Value (2011-2016)
  8.1.1 Spain Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Osteoporosis Drugs Sales Price Trend (2011-2016)
8.2 Spain Osteoporosis Drugs Sales and Market Share by Manufacturers
8.3 Spain Osteoporosis Drugs Sales and Market Share by Type
8.4 Spain Osteoporosis Drugs Sales and Market Share by Application

9 BENELUX OSTEOPOROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Osteoporosis Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Osteoporosis Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Osteoporosis Drugs Sales Price Trend (2011-2016)
9.2 Benelux Osteoporosis Drugs Sales and Market Share by Manufacturers
9.3 Benelux Osteoporosis Drugs Sales and Market Share by Type
9.4 Benelux Osteoporosis Drugs Sales and Market Share by Application

10 EUROPE OSTEOPOROSIS DRUGS MANUFACTURERS ANALYSIS

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Osteoporosis Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Merck & Co
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Osteoporosis Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Merck & Co Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Osteoporosis Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Osteoporosis Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Abiogen Pharma
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Osteoporosis Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Abiogen Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Deltanoid Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Osteoporosis Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Deltanoid Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 F. Hoffmann La Roche
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Osteoporosis Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 F. Hoffmann La Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 GlaxoSmithKline
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Osteoporosis Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 GlaxoSmithKline Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 IMMD
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Osteoporosis Drugs Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 IMMD Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Ligand Pharmaceuticals
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Osteoporosis Drugs Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Ligand Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 NPS Pharma
10.12 Pantarhei Bioscience
10.13 Pfizer
10.14 PhytoHealth
10.15 Radius Health
10.16 Shenzhen Haiwang
10.17 Kunming Baker Norton
10.18 Chia Tai Tianqing

11 OSTEOPOROSIS DRUGS MANUFACTURING COST ANALYSIS

11.1 Osteoporosis Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Osteoporosis Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Osteoporosis Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE OSTEOPOROSIS DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Osteoporosis Drugs Sales Forecast (2016-2021)
14.2 France Osteoporosis Drugs Sales Forecast (2016-2021)
14.3 UK Osteoporosis Drugs Sales Forecast (2016-2021)
14.4 Russia Osteoporosis Drugs Sales Forecast (2016-2021)
14.5 Italy Osteoporosis Drugs Sales Forecast (2016-2021)
14.6 Spain Osteoporosis Drugs Sales Forecast (2016-2021)
14.7 Benelux Osteoporosis Drugs Sales Forecast (2016-2021)
14.8 Europe Osteoporosis Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Osteoporosis Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoporosis Drugs
Table Classification of Osteoporosis Drugs
Figure Europe Sales Market Share of Osteoporosis Drugs by Type in 2015
Figure Antiresorptive Medications Picture
Figure Anabolic Medications Picture
Figure Others Picture
Table Application of Osteoporosis Drugs
Figure Europe Sales Market Share of Osteoporosis Drugs by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Others Examples
Figure Germany Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure France Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure UK Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Osteoporosis Drugs Sales and Growth Rate (2011-2021)
Figure Europe Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Table Europe Osteoporosis Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Osteoporosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers
Figure 2016 Osteoporosis Drugs Sales Share by Manufacturers
Table Europe Osteoporosis Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Osteoporosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Osteoporosis Drugs Revenue Share by Manufacturers
Table 2016 Europe Osteoporosis Drugs Revenue Share by Manufacturers
Table Europe Osteoporosis Drugs Sales and Market Share by Type (2011-2016)
Table Europe Osteoporosis Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Osteoporosis Drugs by Type (2011-2016)
Figure Europe Osteoporosis Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Osteoporosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Osteoporosis Drugs by Type (2011-2016)
Figure Europe Osteoporosis Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Osteoporosis Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Osteoporosis Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Osteoporosis Drugs by Countries (2011-2016)
Table Europe Osteoporosis Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Osteoporosis Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Osteoporosis Drugs by Countries (2011-2016)
Table Europe Osteoporosis Drugs Sales and Market Share by Application (2011-2016)
Table Europe Osteoporosis Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Osteoporosis Drugs by Application (2011-2016)
Figure Germany Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure Germany Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Osteoporosis Drugs Sales Price Trend (2011-2016)
Table Germany Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Osteoporosis Drugs Sales by Type (2015 and 2016)
Table Germany Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table Germany Osteoporosis Drugs Sales by Application (2015 and 2016)
Table Germany Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure France Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure France Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure France Osteoporosis Drugs Sales Price Trend (2011-2016)
Table France Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table France Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table France Osteoporosis Drugs Sales by Type (2015 and 2016)
Table France Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table France Osteoporosis Drugs Sales by Application (2015 and 2016)
Table France Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure UK Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure UK Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure UK Osteoporosis Drugs Sales Price Trend (2011-2016)
Table UK Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table UK Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Osteoporosis Drugs Sales by Type (2015 and 2016)
Table UK Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table UK Osteoporosis Drugs Sales by Application (2015 and 2016)
Table UK Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure Russia Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure Russia Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Osteoporosis Drugs Sales Price Trend (2011-2016)
Table Russia Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Osteoporosis Drugs Sales by Type (2015 and 2016)
Table Russia Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table Russia Osteoporosis Drugs Sales by Application (2015 and 2016)
Table Russia Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure Italy Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure Italy Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Osteoporosis Drugs Sales Price Trend (2011-2016)
Table Italy Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Osteoporosis Drugs Sales by Type (2015 and 2016)
Table Italy Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table Italy Osteoporosis Drugs Sales by Application (2015 and 2016)
Table Italy Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure Spain Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure Spain Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Osteoporosis Drugs Sales Price Trend (2011-2016)
Table Spain Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Osteoporosis Drugs Sales by Type (2015 and 2016)
Table Spain Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table Spain Osteoporosis Drugs Sales by Application (2015 and 2016)
Table Spain Osteoporosis Drugs Market Share by Application (2015 and 2016)
Figure Benelux Osteoporosis Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Osteoporosis Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Osteoporosis Drugs Sales Price Trend (2011-2016)
Table Benelux Osteoporosis Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Osteoporosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Osteoporosis Drugs Sales by Type (2015 and 2016)
Table Benelux Osteoporosis Drugs Market Share by Type (2015 and 2016)
Table Benelux Osteoporosis Drugs Sales by Application (2015 and 2016)
Table Benelux Osteoporosis Drugs Market Share by Application (2015 and 2016)
Table Osteoporosis Drugs Basic Information List
Table Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Osteoporosis Drugs Sales Market Share (2011-2016)
Table Merck & Co Basic Information List
Table Merck & Co Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co Osteoporosis Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Osteoporosis Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Osteoporosis Drugs Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Osteoporosis Drugs Sales Market Share (2011-2016)
Table Deltanoid Pharmaceuticals Basic Information List
Table Deltanoid Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Deltanoid Pharmaceuticals Osteoporosis Drugs Sales Market Share (2011-2016)
Table F. Hoffmann La Roche Basic Information List
Table F. Hoffmann La Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann La Roche Osteoporosis Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Osteoporosis Drugs Sales Market Share (2011-2016)
Table IMMD Basic Information List
Table IMMD Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table IMMD Osteoporosis Drugs Sales Market Share (2011-2016)
Table Ligand Pharmaceuticals Basic Information List
Table Ligand Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ligand Pharmaceuticals Osteoporosis Drugs Sales Market Share (2011-2016)
Table NPS Pharma Basic Information List
Table NPS Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NPS Pharma Osteoporosis Drugs Sales Market Share (2011-2016)
Table Pantarhei Bioscience Basic Information List
Table Pantarhei Bioscience Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pantarhei Bioscience Osteoporosis Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Osteoporosis Drugs Sales Market Share (2011-2016)
Table PhytoHealth Basic Information List
Table PhytoHealth Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table PhytoHealth Osteoporosis Drugs Sales Market Share (2011-2016)
Table Radius Health Basic Information List
Table Radius Health Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Radius Health Osteoporosis Drugs Sales Market Share (2011-2016)
Table Shenzhen Haiwang Basic Information List
Table Shenzhen Haiwang Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shenzhen Haiwang Osteoporosis Drugs Sales Market Share (2011-2016)
Table Kunming Baker Norton Basic Information List
Table Kunming Baker Norton Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kunming Baker Norton Osteoporosis Drugs Sales Market Share (2011-2016)
Table Chia Tai Tianqing Basic Information List
Table Chia Tai Tianqing Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chia Tai Tianqing Osteoporosis Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoporosis Drugs
Figure Manufacturing Process Analysis of Osteoporosis Drugs
Figure Osteoporosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
Table Major Buyers of Osteoporosis Drugs
Table Distributors/Traders List
Figure Germany Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Osteoporosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Osteoporosis Drugs Sales Forecast by Type (2016-2021)
Table Europe Osteoporosis Drugs Sales Forecast by Application (2016-2021)